Strategy repurchases $208.2 million in STRC shares, triples recent Bitcoin spend
Strategy, a prominent Bitcoin-focused corporate treasury and investment firm led by Michael Saylor, spent $208.2 million repurchasing its STRC preferred shares last week, a figure more than three times its Bitcoin investment for the same period.
STRC buybacks overshadow Bitcoin acquisitions
According to a Monday 8-K filing with the Securities and Exchange Commission, Strategy allocated $65.5 million to purchase 811 Bitcoin at an average price of $80,846 per coin. In contrast, the company spent heavily on its STRC preferred share buyback program, marking a substantial prioritization of STRC over further Bitcoin accumulation during the week.
The company’s use of capital for share buybacks follows a broader pattern observed in October, when it repurchased $664 million in STRC shares between October 1 and October 25. Over that same period, Strategy invested about $72 million in Bitcoin, reflecting a consistent trend of STRC buybacks outpacing direct Bitcoin buys.
Strategy’s recent filing indicates the company spent $208.2 million on STRC repurchases last week, compared to $65.5 million allocated for buying 811 Bitcoin, continuing a recent pattern of prioritizing share buybacks over Bitcoin acquisitions.
This emphasis on preferred share buybacks comes as the price of STRC preferred stock advanced by 0.1% in pre-market trading on Monday, reaching $99.22. This remains roughly 0.8% below the company’s $100 target price, a threshold the firm uses to govern new issuances.
Company policy prohibits issuing new STRC preferred shares below the $100 mark, limiting available funding from this source unless the stock rises above the target price.
Strategy sold about 1.18 million of its MSTR shares, raising $164 million in net proceeds. Of this amount, $65.5 million was used for Bitcoin purchases, while the remaining $98.5 million was allocated to its US dollar cash reserves.
As of Sunday, the company reported holding $132.7 million in USD cash and $4.79 billion in a separate US dollar reserve. These reserves position Strategy to continue both strategic share repurchases and Bitcoin investments amid market volatility.
Metaplanet follows with multi-billion yen share buyback
Metaplanet, a Tokyo-based Bitcoin treasury company, also reported major share buybacks. The firm spent approximately 25.27 billion yen ($160 million) to repurchase 96.45 million of its common shares from October 14 through Saturday. This represented around 7.1% of its issued shares.
Large-scale buybacks by both Strategy and Metaplanet reflect persistent efforts by crypto-focused companies to manage their capital structure while pursuing Bitcoin acquisition strategies.
Mini dictionary: Metaplanet is a Japanese publicly listed company known for its significant corporate Bitcoin holdings, similar to US-based MicroStrategy, and frequently engages in treasury management involving both equity buybacks and digital asset purchases.
| Strategy | Last week | $208.2 million (STRC) | Not disclosed | $65.5 million (811 BTC) |
| Strategy | Oct 1 – Oct 25 | $664 million (STRC) | Not disclosed | $72 million (BTC) |
| Metaplanet | Oct 14 – Saturday | 25.27 billion yen ($160 million) | 96.45 million | Not disclosed |
The continued accumulation of Bitcoin and share repurchases by companies such as Strategy and Metaplanet come as institutional discussion around Bitcoin’s hashrate and market prospects intensifies.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
